James Davidson joined the company in 1997; shortly after gaining his PhD from the Department of Chemistry at the University of Cambridge.
During his time at Vernalis, he has worked on numerous protein target classes and therapeutic indications and is a co-inventor on over 20 patents. Most recently he led the chemistry efforts on projects targeting Bcl-2 family proteins for cancer.
James is currently the Director of Chemistry; with responsibility for synthetic and medicinal chemistry, as well as computational chemistry and cheminformatics.
